Wealth Manager - the site for professional investment managers

Register to get unlimited access to all of Citywire’s Fund Manager database. Registration is free and only takes a minute.

Woodford plans to pour £30m into struggling Irish biotech firm

Woodford plans to pour £30m into struggling Irish biotech firm

Neil Woodford has expressed an interest in investing $50 million (£30 million) in an Irish biotech firm as part of a $100 million (£59 million) fundraising.

Prothena Corporation, a clinical stage biotechnology specialist focused on antibody development, is planning to use the proceeds for ongoing research and development purposes.

Shares in Prothena, which is headquartered in Dublin but traded on the Nasdaq, have plunged by 50% over the past three months after its latest trial data proved less positive than investors had hoped.

Despite this Prothena has reported a strong start to the year, with net income of $17.9 million (£10.5 million) in the first quarter compared with a net loss of $9 million (£5.3 million) in the equivalent period of 2013. It also has $195.1 million (£115 million) of cash on its balance sheet and no outstanding debt.

Citywire A-rated Woodford (pictured) has already begun populating his new fund’s portfolio with several other biotech businesses.

Leave a comment!

Please sign in or register to comment. It is free to register and only takes a minute or two.
Citywire TV
Play Volatility spike: How ETFs can soften the blow

Volatility spike: How ETFs can soften the blow

ETFGI’s Deborah Fuhr discusses the role of ETFs in client portfolios during volatile market conditions

Play Winter market warmers, the post QE world and timing the Fed

Winter market warmers, the post QE world and timing the Fed

This week’s episode of Investment Pulse looks at the winding down of quantitative easing, whether to try and time a US Federal Reserve rate rise and if strong seasonal performers can reverse recent market slumps

Play JPM’s Negyal: Back divis to temper EM volatility

JPM’s Negyal: Back divis to temper EM volatility

Omar Negyal, co-manager of the JPMorgan Global Emerging Markets Income trust, says a dividend approach to emerging markets reduces the volatility of investing in the asset class.

Wealth Manager on Twitter